All SightGlass Vision Articles

Natalia Trela-McDonald Named Head of Research and Development at SightGlass Vision

November 20, 2025 DALLAS — Natalia Trela-McDonald has officially been named Senior Director of R&D and Technology at SightGlass Vision. Trela-McDonald brings...

680

SightGlass Vision’s 18-Month Data on DOT Spectacles Proves Myopia Efficacy

SightGlass Vision is set to present its 18-month data the 2025 Academy Meeting in Boston. October 6, 2025 DALLAS — SightGlass Vision...

620

SightGlass Vision’s DOT Spectacles Available in U.K. for Early Access

September 22, 2025 SOUTHAMPTON — SightGlass Vision announced that its Diffusion Optics Technology (DOT) spectacles for myopia control are now available for...

1.1K

SightGlass Vision Shares Latest DOT Spectacle Findings at ARVO 2025

May 5, 2025 DALLAS — SightGlass Vision is presenting the latest findings on its DOT spectacles at the 2025 Association for Research...

1.8K

The Proliferation of Myopia Management Spectacles

May 1, 2025 By Philip Cheng, B.Optom (Melb), GCOT, IACMM, FIAOMC When it comes to correcting and managing myopia, glasses immediately spring...

3.2K

DOT Spectacle Lenses Prove Efficacious at Slowing Myopia Progression in Real-World Setting

sponsored content February 3, 2025 By Kylvin Ho, OD, FIAOMC Practicing optometry in Canada has given me the opportunity to try different...

In The Pipeline

Eye-Tracking Software for Myopia Prevention

July 23, 2024 NovaSight, an Israeli Health-Tech company focusing on eye-tracking-based vision care solutions, is developing TrackSight, a software-as-a-service (SaaS) solution for...

How Safe and Effective Are Next-Generation Spectacle Lenses for Myopia Management?

March 1, 2024 By Nabin Paudel, BOptom, PhD Myopia is a growing public health concern that will affect an estimated 4.7 billion...

1.6K

SightGlass’ DOT Spectacle Lenses Receive FDA Breakthrough Device Designation

February 14, 2024 LOS ALTOS, Calif. — SightGlass Vision’s Diffusion Optics Technology (DOT) spectacle lenses have received Breakthrough Device designation from the...

1.2K

Debbie Jones, Jill Woods Discuss SightGlass Vision’s DOT Spectacles at THE Myopia Meeting

January 15, 2024 TORONTO – At THE Myopia Meeting held here Sunday, December 3, 2023, Debbie Jones, BSc(Hons), FCOptom, FAAO, and Jill...

The Impact of Two Spectacle Myopia Control Designs on Identical Twins

sponsored content December 15, 2023 By Tina Goodhew, OD, with commentary by Cristina Schnider OD, MBA, FAAO Though not yet available in...

1.5K

THE Myopia Meeting Hosts Final Live Meeting of 2023 in Toronto

December 4, 2023 TORONTO — On Sunday, December 3, leaders in the eye care field gathered here for the fourth and final...

1.8K

SightGlass Shares Positive Results at American Academy of Optometry 2023

October 16, 2023 NEW ORLEANS, La. — At the American Academy of Optometry’s 2023 Annual Meeting, SightGlass Vision shared three studies that...

Next-Gen Spectacle Designs for Myopia Management: What We Know Now

October 2, 2023 By Nabin Paudel, BOptom, PhD Myopia management using optical interventions, particularly spectacle lenses, has evolved over the past few...

1.5K

SightGlass Vision Releases First White Paper on DOT Lenses

September 20, 2023 LOS ALTOS, Calif. — SightGlass Vision’s Diffusion Optics Technology (DOT) spectacle lenses are the subject of a recently released...

1.6K

SightGlass Presents Four-Year Results of CYPRESS Trial at CCOS

September 5, 2023 CHANGSHA, China — At the Congress of the Chinese Ophthalmological Society (CCOS) in Changsha, SightGlass Vision shared the four-year results...

VTI Appoints Dr. Juan Carlos Aragón as CEO and Executive Director

ATLANTA — Visioneering Technologies, Inc. (ASX: VTI), a medical device company and producer of the NaturalVue Multifocal 1 Day Contact Lenses, announced...

1.7K

THE Myopia Meeting Brings Live Myopia Management Education to Canada

November 9, 2022 TORONTO – With Canada the first country to establish myopia management as the standard of care and offering more...

1.8K

SightGlass Vision’s DOT Spectacles Found to be Effective for Reducing Myopia Progression

October 25, 2022 LOS ALTOS, Calif. — New findings from SightGlass Vision’s three-year CYPRESS clinical trial have highlighted the efficacy of the...

2.5K

The International Myopia Conference Breaks All Records

September 12, 2022 ROTTERDAM, The Netherlands — After a three-year hiatus, the International Myopia Conference returned with its best attended event since...

2.2K

SightGlass Vision Spectacles Slow Myopia Progression for 6- and 7-Year-Olds

June 23, 2022 PALO ALTO, Calif. — In analyzing two-year data from SightGlass Vision’s CYPRESS clinical trial, experts have learned that the...

3.5K

Editor’s Perspective

Innovative Myopia Control Spectacle Lenses on the Horizon

June 1, 2022 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE There is good reason to slow the progression of juvenile-onset myopia....

3.0K

Review of Myopia Management Spectacles: MiYOSMART, Stellest, and SightGlass

June 1, 2022 By Dean Psarakis, B.Optom, Senior Research Optometrist, Brien Holden Vision Institute Novel spectacle designs comprising D.I.M.S., H.A.L.T., and D.O.T....

10.5K

ECPs Share Real-World Experience with DOT Spectacle Lenses

sponsored content June 1, 2022 One of few spectacle lenses available to slow the progression of myopia, SightGlass Vision’s novel Diffusion Optics...

2.1K

Resources & Multimedia

‘Up Close With’ Juan Carlos Aragón of CooperVision Specialty EyeCare

April 4, 2022 To find out what’s new with CooperVision Specialty EyeCare, particularly its growing list of orthokeratology materials and designs, Review...

2.3K